Skip to content

The Revaluation Study of Jian Pi Qing Ha Granules for Remedying Type 2 Diabetes, Deficiency of Both Qi and Yin

The Revaluation Study of Jian Pi Qing Ha Granules for Remedying Type 2 Diabetes, Deficiency of Both Qi and Yin

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16007754
Enrollment
Unknown
Registered
2016-01-13
Start date
2016-01-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Two groups:Jian Pi Qing Ha Granules versus placebo

Sponsors

Shanghai Hospital affiliated with Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All patients who are in accordance with the diagnostic criteria and HbA1C ranges from 7% to 9%; 2. No diabetic microangiopathy,or mild microangiopathy complications(urine microalbumin /creatinine<30mg/g,retinopathy<=I period; 3. Aged from 18 to 65 years old, Male or female; 4. blood pressure<=160/100mmHg; 5. Anyone who had signed the consent form can be involved in Laboratory cases.

Exclusion criteria

Exclusion criteria: 1. pregnant or breast feeding woman; 2. with severe cardiac, liver ,kidney complication, or other severe primary disease, psychopath; 3. Being experienced acute myocardial?infarction or heart stent implantation/coronary/bypass/operation in recent 3 months; 4. Being diagonesed with acute stroke in recent 3 months; 5. Being experienced severe and emergency diabetes complications during past 30 days, including DKA, HHS; 6. Being allergic to medicines used in therapeutic.

Design outcomes

Primary

MeasureTime frame
HbA1c;HbA1c;

Secondary

MeasureTime frame
glucose;

Countries

China

Contacts

Public ContactZheng Yao
yaozheng8848@163.com+86 13636616528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026